- Home
- QLI
as 07-26-2024 4:00pm EST
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.
| Founded: | N/A | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 26.4M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 44.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.78 - $6.69 | Next Earning Date: | 08-06-2024 |
| Revenue: | $46,471,478 | Revenue Growth: | -28.35% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Qilian International Holding Group Ltd. News
QLI Breaking Stock News: Dive into QLI Ticker-Specific Updates for Smart Investing
MT Newswires
14 days ago
Qilian International Holding Regains Nasdaq Compliance
PR Newswire
14 days ago
Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule
PR Newswire
a month ago
Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split
PR Newswire
2 months ago
Qilian International plans to adjust industrial investment
GlobeNewswire
6 months ago
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
GlobeNewswire
6 months ago
Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium
Zacks
6 months ago
Is Heartland Financial USA (HTLF) Stock Undervalued Right Now?
PR Newswire
6 months ago
Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
Compare QLI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QLI Qilian International Holding Group Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.